Search Results
Our Team Chester Alper, MD Senior Investigator, PCMM Professor of Pediatrics, Harvard Medical School Dr. Chester Alper received his M.D. from Harvard Medical School in 1956. In addition to practicing medicine in the late 1950s, both in the U.S. Navy and …
Principal Investigator Trista E. North, PhD Professor of Pediatrics, Harvard Medical School CV | Twitter | LinkedIn Dr. Trista E. North is Principle Investigator in the the Stem Cell Program and Department of Hematology/Oncology at Boston Children’s …
Brain-based biomarkers of language acquisition in neurodevelopmental disorders Several studies in our lab focus on identifying biomarkers of language development in young children at risk for severe language impairment, including infant siblings of …
Location: 1 Autumn St. 4th floor (#456) Boston, MA 02215 Contact Address: Dr. Emi Takahashi Division of Newborn Medicine, Department of Medicine, Boston Children’s Hospital. Email: emi@nmr.mgh.harvard.edu Job Opportunities Graduate: We accept graduate …
Postdoctoral Research Fellow There are currently no open positions. positions-available Positions Available … Positions Available …
Hidde Ploegh (born in the Netherlands) is an immunologist at Boston Children’s Hospital. He is well-known for his contributions in understanding antigen processing and the evasion of the immune system by viruses. Ploegh received a Bachelor of Science …
Intraocular inflammation, oncomodulin, and optic nerve regeneration. Due to its accessibility, simple anatomy, and functional importance, the optic nerve has been widely studied for insights into positive and negative regulators of axon regeneration in …
Inosine, stroke and spinal cord injury. Earlier studies from our lab showed that inosine, a metabolite of adenosine, acts through a direct intracellular mechanism to stimulate axon outgrowth from neurons in cell culture 1 . We went on to identify the …
Here we provide a list of suggested links. Although we have reviewed the content of these sites and believe they offer appropriate information on neuromuscular disease and related topics, we are not responsible for the actual publications on these sites. …
Congenital Fiber-Type Disproportion (CFTD) designates a heterogenous group of muscle disorders in which slow twitch (type 1) fibers are significantly (12 – 40%) smaller than their fast twitch (type 2) fiber counterparts ( Clarke 2011 ; Kissiedu and …